Study: Treatment-resistant childhood leukemia tied to gene

01/12/2009 | Yahoo!

Dutch and German researchers found that children with a subtype of acute lymphoblastic leukemia who have the BCR-ABL1 fusion gene are more prone to relapse than patients without the gene. The finding suggests that carriers of the gene should get more intensive treatment with medicines already on the market "or with new, more-targeted drugs for which the biology of the BCR-ABL1-like subtype needs further study," the lead scientist said.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR